Clinical Trial Update: A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021) [Phase 3]

View source ↗

Summary

This update reports an ongoing Phase 3 clinical trial of Sac-TMT for non-HRD positive advanced ovarian cancer that is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Sac-TMT

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Ovarian Neoplasms, Ovarian Cancer | Phase 3 | Status: RECRUITING